Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.41 |
| ▸ | TACR2 | P21452 | 2/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | SHBG | P04278 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.41 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | TST | Q16762 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29155877 | 0.98 | ESR1 (0.39) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL8670838 | 0.98 | ESR1 (0.42) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL3382982 | 0.88 | DNM1 (0.46) | TP53 | |
| SCHEMBL11128949 | 0.88 | DNM1 (0.46) | TP53 | |
| SCHEMBL734355 | 0.87 | TP53 (0.37) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL13766075 | 0.86 | CA1 (0.41) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| Hydrochloric Acid SCHEMBL28908434 | 0.86 | DNM1 (0.44) | TP53 | |
| Phosphine SCHEMBL27539974 | 0.86 | DNM1 (0.44) | TP53 | |
| SCHEMBL8670612 | 0.86 | LPL (0.41) | TP53LPLLIPG | |
| SCHEMBL10970027 | 0.85 | HPGD (0.40) | ALDH1A1CHRM2ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0757052-B1 | Di-substituted 1,2-dioxetane compounds having increased water solubility and assay compositions | GOVERNORS OF WAYNE STATE BOARD (US) | 2003-02-19 | — | — | EP | claimed |
| EP-0757248-B1 | Improved capsule chemistry analytical methods employing dioxetane chemiluminescence | GOVERNORS BOARD OF (US) | 2001-05-23 | — | — | EP | claimed |
| EP-0630884-B1 | Method and composition providing enhanced chemiluminescence from chemiluminescent compounds using dicationic surfactants | LUMIGEN INC (US) | 1998-12-23 | — | — | EP | claimed |
| US-20170210825-A1 | MONOSPECIFIC AND MULTISPECIFIC ANTIBODIES AND METHOD OF USE | BAYER IP GMBH (US) | 2017-07-27 | — | — | US | disclosed |
| US-9624309-B2 | Monospecific and multispecific antibodies and method of use | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2017-04-18 | — | — | US | disclosed |
| EP-2532676-B1 | Protease-regulated antibody | Bayer Pharma AG (DE) | 2017-03-22 | — | — | EP | disclosed |
| EP-1963372-B1 | ANTI-MN ANTIBODIES AND METHODS OF USING THE SAME | BAYER HEALTHCARE LLC (US) | 2013-07-03 | — | — | EP | disclosed |
| EP-2532676-A1 | Protease-regulated antibody | Bayer Pharma Aktiengesellschaft (DE) | 2012-12-12 | — | — | EP | disclosed |
| US-20120301468-A1 | ANTI-MN ANTIBODIES AND METHODS OF USING SAME | BAYER HEALTHCARE LLC (US) | 2012-11-29 | — | — | US | disclosed |
| EP-2476706-A2 | Anti-MN antibodies and methods of using same | Bayer HealthCare LLC (US) | 2012-07-18 | — | — | EP | disclosed |
| US-8168758-B2 | Anti-MN antibodies and methods of using same | BAYER HEALTHCARE LLC (US) | 2012-05-01 | — | — | US | disclosed |
| WO-2006098724-A1 | METHODS FOR TREATING HIV BY INHIBITING CD4 DOWN-MODULATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-09-21 | — | — | WO | disclosed |
| WO-2006076735-A2 | REGULATING EXPRESSION OF TRANSIENT RECEPTOR POTENTIAL CHANNEL GENES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-07-20 | — | — | WO | disclosed |
| EP-1558932-A2 | UNCOUPLED COLLAGEN SYNTHESIS AND DEGRADATION ASSAYS | Barnes-Jewish Hospital (US) | 2005-08-03 | — | — | EP | disclosed |
| US-20040203072-A1 | Uncoupled collagen synthesis and degradation assays | BARNES-JEWISH HOSPITAL | 2004-10-14 | — | — | US | disclosed |
| EP-1141726-B1 | IMMUNOASSAYS TO DETECT DISEASES OR DISEASE SUSCEPTIBILITY TRAITS | CA TX INC (US) | 2004-08-04 | — | — | EP | disclosed |
| WO-2004043237-A2 | UNCOUPLED COLLAGEN SYNTHESIS AND DEGRADATION ASSAYS | BARNES-JEWISH HOSPITAL (US) | 2004-05-27 | — | — | WO | disclosed |
| US-6025149-A | CHEAPER, NONINVASIVE QUANTITATIVE ANALYSIS OF URINE SAMPLE FROM PREGNANT WOMAN IN SECOND OR THIRD TRIMESTER FOR HUMAN CHORIONIC GONADOTROPHIN LEVEL, COMPARING TO STANDARDS; INCREASED OR DECREASED LEVEL INDICATES RISK | YALE UNIVERSITY (US) | 2000-02-15 | — | — | US | disclosed |
| US-5770176-A | CORRELATING SPECIFIC BINDING OF NUCLEIC ACID REAGENT, LIGANDS AND ANTIBODIES IN SAMPLE WITH PRESENCE OF RECEPTORS | CHIRON DIAGNOSTICS CORPORATION (US) | 1998-06-23 | — | — | US | disclosed |
| US-5716853-A | ENZYME-LINKED IMMUNOSORBENT ASSAY | CHIRON DIAGNOSTICS CORPORATION (US) | 1998-02-10 | — | — | US | disclosed |